Literature DB >> 11589381

Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis. Indicator of ileocaecal and colorectal affection.

T Ljung1, M Herulf, E Beijer, H Jacobsson, J Lundberg, Y Finkel, P M Hellström.   

Abstract

BACKGROUND: Nitric oxide (NO) production is increased in inflammatory bowel disease (IBD). Measurements of luminal NO in Crohn disease and ulcerative colitis have revealed that levels are increased during active disease. We aim to evaluate whether rectal measurements of NO can reveal active disease of the colon as well as ileum.
METHODS: Sixteen children with active Crohn disease in the ileocaecal or colorectal regions of the gut and 6 children with active ulcerative colitis were compared to a group of 14 healthy children. Gaseous samples for analysis of luminal NO were collected using a Foley catheter inserted into rectum. The balloon of the catheter was filled with NO-free air and incubated for 10 min. After aspiration, samples were analysed using chemiluminescence. Values are expressed as median and range.
RESULTS: In healthy children, rectal NO values were 60 (0-275) ppb. In children with Crohn disease of the colorectal region, NO concentrations were 5,675 (300-49,350) ppb (P < 0.001), while those with Crohn disease of the ileocaecal region had NO levels of 2,625 (300-15,000) ppb (P < 0.01). In children with ulcerative colitis, NO values of 5,500 (950-34,000) ppb were found (P < 0.001).
CONCLUSION: Rectal NO levels are greatly increased in children with IBD. Highest values were found in patients with colorectal engagement, but rectal NO was increased also in ileocaecal disease. Rectal sampling of luminal NO is a simple and minimally invasive method and should be considered a diagnostic tool for intestinal inflammatory activity in children regardless of primary disease location.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589381     DOI: 10.1080/003655201750422684

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected mice.

Authors:  Bruce A Vallance; Wanyin Deng; Myriam De Grado; Crystal Chan; Kevan Jacobson; B Brett Finlay
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis.

Authors:  Li Tian; Yu-Xin Huang; Min Tian; Wei Gao; Qing Chang
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

3.  Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis.

Authors:  John Leung; Ann Nguyen-Traxler; Erika M Lee; Jason S Yip; Joel V Weinstock; Walter W Chan; Peter Ngo; Barbara J Weinstein; Peter A Bonis
Journal:  Allergy Asthma Proc       Date:  2012 Nov-Dec       Impact factor: 2.587

4.  Rectal nitric oxide gas and stool cytokine levels during the course of infectious gastroenteritis.

Authors:  Anders Enocksson; Jon Lundberg; Eddie Weitzberg; Anna Norrby-Teglund; Bo Svenungsson
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

5.  Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases.

Authors:  Golshid Jahanshahi; Vian Motavasel; Ali Rezaie; Ali A Hashtroudi; Naser E Daryani; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.